We are monitoring the impact of COVID-19 & Recession alarm on Latin America Liquid Biopsy Market Get in touch with us for detailed analysis Know More
Share on

Latin America Liquid Biopsy Market Research Report – Segmented By Cancer Type, Sample Type, Diagnostic Approach, End Users, Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2022 to 2027)

Published: January, 2022
ID: 893
Pages: 145

Latin America Liquid Biopsy Market Size (2022 to 2027)

The Latin American Liquid Biopsy Market size is predicted to grow at a CAGR of 27.6% during the forecast period. The market size is projected to value USD 648.30 million by 2027 from USD 191.66 million in 2022.

The growth of the Latin American Liquid Biopsy Market is majorly driven by the increasing number of infectious diseases and increased focus on developing new technologies in the healthcare domain. Growing prominence for developing novel diagnostics tools for various cancer cases is also ascribed to bolster the market's demand. Growing investments in healthcare to develop accurate techniques by private and public organizations propel the market's growth rate. Additionally, the increasing prevalence of companion diagnostics and the rising demand to develop innovative technologies in favor of the end-users are anticipated to fuel the market's demand. Favorable reimbursement policies and increasing awareness over precision medicine utilization are further flourishing the growth rate of the liquid biopsy market in Latin America.

Secondarily, the rising prevalence of cancer, preference for invasive procedures, and funding in research and development for advancement in the liquid biopsy are anticipated to increase market demand. These are some of the factors driving the growth of this market in Brazil. Furthermore, liquid biopsy can detect cancer early, which helps the doctors provide proper treatment procedures, which is lucratively prompting market growth in Mexico.

Stringent government policies and transportation restrictions due to lockdown are causing downturn growth of the liquid biopsy market. COVID-19 outbreak is emphasizing the companies to develop new techniques. Novel Coronavirus can leave long-term effects on trade practices even after the Liquid Biopsy market lockdown period.

However, factors like the dearth of skilled persons and lack of proper knowledge in rural areas hinder the market's growth rate. In addition, the high cost of installing and maintaining the devices in the clinical laboratories is slowly impeding the demand of the liquid biopsy market. Growing complications in the real-time monitoring procedures are slowly hampering the demand of the market in Latin America. Besides, people in rural areas are less aware of the treatment procedures available, which is gradually limiting the market's growth rate.

This research report on the Latin American Liquid Biopsy Market has been segmented and sub-segmented market into the following categories:

By Cancer Type: 

  • Lung Cancer
  • Pancreatic Cancer
  • Leukemia
  • Other Visceral Cancers

By Diagnostic Approach: 

  • Circulating Tumour cells (CTC)
  • Circulating Tumour DNA (ctDNA)
  • RNA in exosomes
  • Extra-Cellular Vesicles

By End-Users: 

  • Reference Laboratories
  • Hospital/Physician Laboratories
  • Academic and Research Centers
  • Other End Users

By Country: 

  • Brazil
  • Argentina
  • Chile
  • Mexico
  • Rest of Latin America

Geographically, the Brazilian market is the largest contributor to the Latin American liquid biopsy market. In Brazil, factors like the rising prevalence of different types of cancer and quick diagnostic technology requirements enable market growth. The growing geriatric population has elevated the demand for the liquid biopsy market. Strong Government support, increased mortality rate due to cancer, and improving healthcare infrastructure drive the market's growth in this part of the world. For a country like Brazil, with a large and aging population, new technologies take time. Therefore, spreading awareness in a rural area is needed to grow the market.

In Mexico, growth in patients who have cancer is fueling the market demand. Cancer is the second leading cause of death. In addition, higher alcohol consumption leads to develop lung, colorectal, breast, and prostate cancer. These factors are accelerating the growth of the liquid biopsy market in this region.

KEY MARKET PLAYERS:

A few prominent companies operating in the Latin America Liquid Biopsy Market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                           

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                              

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                            

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                     

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                      

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                      

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                               

5. Market Segmentation                                                                              

                5.1 By Cancer Type                                                         

                                5.1.1 Lung Cancer                                           

                                5.1.2 Pancreatic Cancer                                

                                5.1.3 Leukemia                                

                                5.1.4 Other Visceral Cancers                                       

                5.2 By Sample Type                                                        

                                5.2.1 Blood                                        

                                5.2.2 Urine                                         

                                5.2.3 Plasma                                      

                                5.2.4 Saliva                                         

                                5.2.5 Cerebrospinal                                        

                5.3 By Diagnostic Approach                                                        

                                5.3.1 Circulating Tumour cells (CTC)                                        

                                5.3.2 Circulating Tumour DNA (ctDNA)                                  

                                5.3.3 RNA in exosomes                                 

                                5.3.4 Extra-Cellular Vesicles                                        

                5.4 By End Users                                                             

                                5.4.1 Reference Laboratories                                     

                                5.4.2 Hospital/Physician Laboratories                                     

                                5.4.3 Academic and Research Centers                                    

                                5.4.4 Other End Users                                   

6. Geographical Analysis                                                                              

                                6.1 Introduction                                              

                                6.2 Brazil                                             

                                6.3 Mexico                                         

                                6.4 Argentina                                    

                                6.5 Rest of Latin America                                             

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                      

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                               

                                7.2.5 Competitive Rivalry within the Industry                                      

8. Market Leaders' Analysis                                                                        

                8.1 Janssen Diagnostics                                                

                                8.1.1 Overview                                

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                            

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Qiagen                                                         

                8.3 Rarecells SAS                                                             

                8.4 Silicon Biosystems                                                   

                8.5 SRI International                                                      

                8.6 Myriad Genetics                                                      

                8.7 Natera                                                          

                8.8 Personal Genome Diagnostics                                                            

                8.9 Sysmex Inostics                                                        

                8.10 Trovagene                                                

                8.11 Exosome Diagnostics                                                           

                8.12 HansaBiomed OU                                                  

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                        

                9.3 Agreements, collaborations and Joint Ventures                                                          

                9.4 New Product Launches                                                          

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  1. Latin America Liquid Biopsy Market, By Region, From 2022 - 2027 (USD Billion)
  2. Latin America Liquid Biopsy Market, By Cancer Type, From 2022 - 2027 (USD Billion)
  3. Latin America Lung Cancer Market, By Region, From 2022 - 2027 (USD Billion)
  4. Latin America Pancreatic Cancer Market, By Region, From 2022 - 2027 (USD Billion)
  5. Latin America Leukemia Market, By Region, From 2022 - 2027 (USD Billion)
  6. Latin America Other Visceral Cancers Market, By Region, From 2022 - 2027 (USD Billion)
  7. Latin America Liquid Biopsy Market, By Sample Type, From 2022 - 2027 (USD Billion)
  8. Latin America Blood Market, By Region, From 2022 - 2027 (USD Billion)
  9. Latin America Urine Market, By Region, From 2022 - 2027 (USD Billion)
  10. Latin America Plasma Market, By Region, From 2022 - 2027 (USD Billion)
  11. Latin America Saliva Market, By Region, From 2022 - 2027 (USD Billion)
  12. Latin America Cerebrospinal Market, By Region, From 2022 - 2027 (USD Billion)
  13. Latin America Liquid Biopsy Market, By Diagnostic Approach, From 2022 - 2027 (USD Billion)
  14. Latin America Circulating Tumour cells (CTC) Market, By Region, From 2022 - 2027 (USD Billion)
  15. Latin America Circulating Tumour DNA (ctDNA) Market, By Region, From 2022 - 2027 (USD Billion)
  16. Latin America RNA in exosomes Market, By Region, From 2022 - 2027 (USD Billion)
  17. Latin America Extra-Cellular Vesicles Market, By Region, From 2022 - 2027 (USD Billion)
  18. Latin America Liquid Biopsy Market, By End Users, From 2022 - 2027 (USD Billion)
  19. Latin America Reference Laboratories Market, By Region, From 2022 - 2027 (USD Billion)
  20. Latin America Hospital/Physician Laboratories Market, By Region, From 2022 - 2027 (USD Billion)
  21. Latin America Academic and Research Centers Market, By Region, From 2022 - 2027 (USD Billion)
  22. Latin America Other End Users Market, By Region, From 2022 - 2027 (USD Billion)
  23. Brazil Liquid Biopsy Market, By Cancer Type, From 2022 - 2027 (USD Billion)
  24. Brazil Liquid Biopsy Market, By Sample Type, From 2022 - 2027 (USD Billion)
  25. Brazil Liquid Biopsy Market, By Diagnostic Approach, From 2022 - 2027 (USD Billion)
  26. Brazil Liquid Biopsy Market, By End Users, From 2022 - 2027 (USD Billion)
  27. Argentina Liquid Biopsy Market, By Cancer Type, From 2022 - 2027 (USD Billion)
  28. Argentina Liquid Biopsy Market, By Sample Type, From 2022 - 2027 (USD Billion)
  29. Argentina Liquid Biopsy Market, By Diagnostic Approach, From 2022 - 2027 (USD Billion)
  30. Argentina Liquid Biopsy Market, By End Users, From 2022 - 2027 (USD Billion)
  31. Mexico Liquid Biopsy Market, By Cancer Type, From 2022 - 2027 (USD Billion)
  32. Mexico Liquid Biopsy Market, By Sample Type, From 2022 - 2027 (USD Billion)
  33. Mexico Liquid Biopsy Market, By Diagnostic Approach, From 2022 - 2027 (USD Billion)
  34. Mexico Liquid Biopsy Market, By End Users, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample